Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nigella Sativa for Radiation Induced Dermatitis Prophylaxis
NCT05693597Phase 2Completed
- Sponsor
- German University in Cairo
- Start
- Jan 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nigella sativa in radiation dermatitis, sponsored by German University in Cairo. Started Jan 2023; status: completed.
02
Drugs
nigella sativa
03
Conditions
radiation dermatitis
Beyond the preview
Go deeper on NCT05693597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05693597.